Prevalence of metabolic syndrome in a sample of population in Erbil city, Iraq
Background and objective: There has been a recent concern about chronic non-communicable diseases in Iraq. The country is undergoing an epidemiological transition with an increasing burden of chronic non-communicable diseases with two-thirds of the people aged 25-65 years old are overweight and one-third are obese. This study aimed to estimate the prevalence of metabolic syndrome with their associated risk factors among a sample of peoples in Erbil city.
Methods: This cross-sectional analytic study was carried out in Erbil city and involved a convenience sample of 566 apparently healthy subjects. A structured direct interview using interviewer administered questionnaire was applied. Anthropometric measures, random blood sugar, cholesterol level, triglyceride level, low-density lipoprotein and high-density lipoprotein were investigated.
Results: The prevalence of metabolic syndrome in the studied sample was 30.6%. The prevalence was higher in females (45.5%) than males (16.3%). Variables like gender (P <0.001), age (P = 0.008), education and marriage (P = 0.001), family history of diabetes mellitus (P = 0.029), hyperlipidemia (P <0.001), hypertension (P = 0.047) and obesity (P = 0.005) were found to be factors that significantly associated with metabolic syndrome.
Conclusions: Metabolic syndrome is prevalent among the studied population. Female gender, old age, marriage, family history of diabetes mellitus, hyperlipidemia, hypertension and obesity may be regarded as risk factors for metabolic syndrome.
Campion J, Milagro FI. Individuality and epigenetics in obesity. Obes Rev 2009; 10: 383-92.
Ferrannini E. Metabolic syndrome: a solution in search of a problem. J Clin Endocrinol Metab2007; 92:396-8.
Danny E, Girish LK. Metabolic syndrome and cardiovascular disease in South Asians. Vasc Health Risk Manag 2009; 5:731-43.
Park HS, Kim SM. Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001. Diabetes Obes Metab2007; 9:50-8.
MOH, WHO. Chronic Non-communicable Diseases Risk Factor Survey in Iraq: A STEP wise Approach. Draft report; 2006. Available From: www.who.int/chp/steps/IraqSTEPSReport2006.pdf. Accessed at 1st Feb 2013.
Lohsoonthorn V, Lertmaharit L. Prevalence of Metabolic Syndrome among Professional and Office Workers in Bangkok, Thailand. J Med Assoc Thai 2007; 90(9):1908-15.
WHO. Physical status: the use and interpretation of anthropometry. Geneva: WHO; 1995. [Report of a WHO Expert Committee] Technical Report Series, 854.
European Society of Cardiology. Guidelines for the management of dyslipidemias. Available From: www.escardio.org/guidelines Accessed at 2nd Jan 2013.
International Diabetes Federation. The IDF Consensus worldwide definition of the metabolic syndrome. Available From: www.idf.org/metabolic-syndrome. Accessed at 7th Jan 2013.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-72.
National Heart, Lung, and Blood Institute. Fourth Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel IV). Guidelines. From: www.nhlbi.nih.gov/files/docs/resources/heart/atp3full.pdf. Accessed: Jan 2013.
National Institute for Health and Care Excellence (formerly National Institute for Health and Clinical Excellence): Guidance. Available From: http://www.ncbi.nlm.nih.gov/books/NBK11822/. Accessed at 8th Feb 2013.
Misra A, Misra R, Wijesuriya M, Banerjee D. The metabolic syndrome in South Asians: continuing escalation and possible solutions. Indian J Med Res 2007; 125(3):345-54.
Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 2007; 77:251-7.
Waleed I A. Helicobacter pylori infection and its relationship to metabolic syndrome: is it a myth or fact? Saudi J Gastroentrol 2011; 17:165-9.
Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Nat Health Stat Report 2009; 13:1-7.
Katzmaryk PT. Targeting the Metabolic Syndrome with Exercise: Evidence from the HERITAGE Family Study. Med Sci Sports Exerc 2003; 35(10):1703-9.
Danny E, Girish LK, Nadya M, Anjali A, Bobby VK. Metabolic syndrome and cardiovascular disease in South Asians. Vasc Health Risk Manag 2009; 5:731-43.
Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH. The US National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005; 67:251-7.
Walmala SP, Lynch J, Horstan M, Mittleman MA, Schenck-Gustafsson K, Orth-Gom´er K. Education and metabolic syndrome. Diabetes care 1999; 22:1999-2003.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).